… warfarin initiation program for ischaemic stroke patients. Based on the age and body weight
of such patients, we … low or high maintenance dose of warfarin to keep within the therapeutic …

… how patient weight and body mass index (BMI) affect warfarin … study, we identified patients
taking warfarin who had an … warfarin dosing, and BMI in obese and nonobese patients. Results…

… Despite BSA being incorporated into pharmacogenetic algorithms, empiric dose
adjustments accounting for body weight are not well established for nongenotype-guided …

… Bleeding risk is higher in obese compared to normal weight individuals who are on warfarin.
These results suggests that BMI plays a role in bleeding events in patients on warfarin. …

… Eccles [10] reported no effect of body weight on maintenance warfarin doses in 80 patients
… significant effect of body weight on response (PT) to maintenance doses of warfarin. A more …

… body weight and BSA will enhance the predictive value of the potential correlation between
body weight and warfarin … the mean warfarin dose for both our overall patient sample and the …

… or VTE in patients with extreme body weights appear safe and effective when compared to
warfarin. … In conclusion, patients of extreme body weights treated with DOACs compared to …

… Based on these results, we conclude that patient age, body weight, and genetic polymorphism
of VKORC1 and CYP2C9 account for about 63% of the variability in warfarin daily dose …

… In our study, the mean body weight is about 11 kg lower than the Caucasian population.However,
by multiple regression, this only explains 0.2 mg of the lower mean dose required. The …

… ) with known baseline body weight at randomization were … to body weight: 1985 (10.9%)
patients were in the low-weight group (≤60 kg), 15 172 (83.6%) were in the midrange weight …